Opioid Long-Term Effectiveness Trial Design Gets Middling Review From FDA Panel

 
• By Brenda Sandburg

Advisory committee agrees that a proposed study protocol could enroll patients but notes the outcome is foreseeable. Industry representative questions whether this postmarketing requirement is necessary.

Pain killer
Proposed study to assess long-term efficacy of opioids gets FDA panel review • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers